Exp Clin Endocrinol Diabetes 2010; 118(7): 410-419
DOI: 10.1055/s-0029-1225615
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Antiproliferative/Cytotoxic Activity of Molecular Iodine and Iodolactones in Various Human Carcinoma Cell Lines. No Interfering with EGF-signaling, but Evidence for Apoptosis

H. Rösner1 , P. Torremante2 , W. Möller1 , R. Gärtner3
  • 1Institut für Zoologie, Universität Hohenheim-Stuttgart, Stuttgart, Germany
  • 2Praxis für Gynäkologie und Geburtshilfe, Ochsenhausen, Germany
  • 3Medizinische Klinik, Universität München, München, Germany
Weitere Informationen

Publikationsverlauf

received 18.02.2009 first decision 24.04.2009

accepted 04.06.2009

Publikationsdatum:
02. Oktober 2009 (online)

Abstract

Twelve human cancer cell lines and one non-malignant cell line were investigated with respect to a potential antiproliferative/cytotoxic activity of molecular iodine and iodolactones. Except CCL221 colon carcinoma cells, the growth of all cancer cell lines decreased if the cells were cultured in the presence of 10 μM molecular iodine (I2) for at least two days. δ-iodolactone (IL, 5 μM) was found to have a similar effect. SH-SY5Y neuroblastoma cells turned out to be most susceptible to both iodine compounds (total inhibition), followed by MCF-7 mammary carcinoma cells (60% and 77.7% inhibition in the presence of I2 respect. IL) and HS24 lung carcinoma cells (36.3% respect. 40.3% inhibition). In contrast, MCF-10 normal mammary epithelial cells were much less affected by the iodine treatment. In both, SH-SY5Y and MCF-7 cells, I2 and IL also abolished EGF-induced promotion of cell growth completely. This effect was, however, not due to an interfering with EGF-signaling, because I2 and IL did not affect the phosphorylation of EGF-receptors, EGF-induced activation of MAP-kinase (Erk1/2), or EGF-induced lamellar actin protrusion. A disruption by molecular iodine of mitochondrial transmembrane electrical potential, which was prevented by a pre-treatment of the cells with N-acetyl-cysteine, supports a mitochondria-mediated apoptotic mechanism.

References

  • 1 Aceves C, Anguiana B, Delgado G. Is iodine a gatekeeper of the integrity of the mammary gland?.  J Mammary Gland Biol Neopl. 2005;  10 189-196
  • 2 Aoshiba K, Yasui S, Nishimura K. et al . Thiol depletion induces apoptosis in cultured lung fibroblasts.  Am J Respir Cell Mol Biol. 1999;  21 54-64
  • 3 Arroyo-Helguera O, Anguiano B, Delgado G. et al . Uptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line.  Endocr Relat Cancer. 2006;  13 1147-1158
  • 4 Arroyo-Helguera O, Rojas E, Delgado G. et al . Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects.  Endocr Rel Cancer. 2008;  15 1003-1011
  • 5 Boeynaems JM, Reagan D, Hubbard WC. Lactoperoxidase-catalyzed iodination of arachidonic aicd: formation of macrolipides.  Lipids. 1981;  16 246-249
  • 6 Chen FY, Han MS, Choon NO. Intracellular thiol depletion causes mitochondrial permeability transition in Ebselen-induced apoptosis.  Arch Biochem Biophys. 2000;  380 319-330
  • 7 Dugrillon A, Bechtner G, Uedelhofen M. et al . Evidence that a iodolactone mediates the inhibitory effect of iodide on thyroid cell proliferation but not on adenosine 3′, 5′ monophosphate formation.  Endocrinol. 1990;  127 337-343
  • 8 Dugrillon A, Gärtner R. δ-Iodolactones decrease epidermal growth factor- induced proliferation of inositol – 1, 4, 5 – triphosphate generation in porcine thyroid follicles – a possible mechanism of growth inhibition by iodide.  Eur J Endocrin. 1995;  132 735-743
  • 9 Dugrillon A, Uedelhofen M, Pisarev A. et al . Identification of δ-iodolactone in iodide treated human goiter and its inhibitory effect on proliferation of human thyroid follicles.  Horm Metab Res. 1994;  26 465-469
  • 10 Eskin BA, Grotowski CE, Conolly CP. et al . Different tissue responses for iodine and iodide in rat thyroid and mammary glands.  Biol Trace Element Res. 1995;  49 9-19
  • 11 Funahashi H, Imai F, Tanaka Y. et al . Suppressive effect of iodine on DMBA-induced breast tumor growth in the rat.  J Surg Oncology. 1996;  61 209-213
  • 12 Garcia-Solis P, Alfaro Y, Anguiano B. et al . Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment. Evidence that I2 prevents cancer promotion.  Mol Cell Endocrinol. 2005;  236 49-57
  • 13 Filomeni G, Rotilio G, Ciriolo MR. Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP-kinase pathway.  The FASEB J. 2003;  17 64-66
  • 14 Ghent WR, Eskin BA, Low DA. et al . Iodine replacement in fibrocystic desease of the breast.  Can J Surg. 1993;  36 453-460
  • 15 Hall AG. The role of gluthadione in the regulation of apoptosis.  Eur J Clin Invest. 1999;  29 238-245
  • 16 He M, Cai J, Go YM. et al . Identification of Thioredoxin-2 as a Regulator of the Mitochondrial Permeability Transition.  Tox Sci. 2008;  105 44-50
  • 17 Honda T, S Coppola L, Ghibelli S. et al . GSH depletion enhances adenoviral bax-induced apoptosis in lung cancer cells.  Canc Gene Ther. 2004;  11 249-255
  • 18 Ji-Yeon B, Soo-Jung A, Wonshik H. et al . Peroxiredoxin I und II inhibit H2O2-induced cell death in MCF-7 cell lines.  J Cell Biochem. 2007;  101 1038-1045
  • 19 Jung A, Rösner H. RAC1-dependent regulation of cholinergically induced lamellar protrusive activity is independent of MAP-kinase and attenuated by active p-JNK.  Dev Neurosci. 2002;  13 2443-2446
  • 20 Katoh N, Funahashi H, Vendoh K. Suppressive effect of iodine preparation on proliferation of DMBA-induced cancer in rat.  J Jpn Soc Cancer. 1994;  29 30-36
  • 21 Kessler JH. The effect of supraphysiologic levels of iodine on patients with cyclic mastalgia.  Breast J. 2004;  10 328-336
  • 22 Kirihari M, Asai Y, Ogawa S. et al . A mild and environmentally benign oxidation of thiols to disulfides.  Synthesis. 2007;  21 3286-3289
  • 23 Langer R, Burzler C, Bechtner G. et al . Influence of iodide and iodolactones on thyroid apoptosis.  Exp Clin Endocrinol Diabetes. 2003;  111 325-329
  • 24 Menon SG, Colemann MC, Walsh SA. et al . Differential susceptibility of non-malignant human breast epithelial cells and breast cancer cells to thiol antioxidant-induced G1-delay.  Antiox Redox Sign. 2005;  7 711-718
  • 25 Rösner H, Fischer H. In growth cones of rat cerebral neurons and human neuroblastoma cells, activation of protein kinase C causes a shift from filopodial to lamellipodial actin dynamics.  Neurosci Lett. 1996;  219 175-178
  • 26 Rösner H, Vacun G, Rebhan M. Muscarinic receptor-mediated induction of actin-driven lamellar protrusions in neuroblastoma cell somata and growth cones. Involvement of protein kinase C.  Eur J Cell Biol. 1995;  66 324-334
  • 27 Rösner H, Williams LAD, Jung A. et al . Disassembly of microtubules and inhibition of neurite outgrowth, neuroblastoma cell proliferation, and MAP-kinase tyrosine dephoisphorylation by dibenzyl-trisulphide.  Biochim Biophys Acta. 2001;  1540 166-177
  • 28 Saitoh M, Nishitoh H, Fujii M. et al . Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1.  The EMBO J. 1998;  17 2596-2606
  • 29 Shrivastava A, Tiwari M, Sinha RA. et al . Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving mitochonria-mediated pathway.  J Biol Chem. 2006;  281 19762-19771
  • 30 Stoddard FR, Brooks AD, Eskin BA. et al . Iodine alters gene expression in the MCF-7 breast cancer cell line: Evidence for an anti-estrogen effect of iodine.  Int J Med Sci. 2008;  5 189-196
  • 31 Torremante P. Mastopathie, Mammkarzinom und Jodlactone.  Dtsch Med Wochenschr. 2004;  129 641-646
  • 32 Upadhyay G, Singh R, Sharma R. et al . Differential action of iodine on mitochondria from human tumoral- and extra-tumoral tissue in inducing the release of apoptogenic proteins.  Mitochondrion. 2002;  2 199-210
  • 33 Zhang R, Al-Lamki L, Bai JW. et al . Thioredoxin-2 Inhibits Mitochondria-Located ASK1-Mediated Apoptosis in a JNK-Independent Manner.  Circ Res. 2004;  94 1483-1490

Correspondence

Prof. Dr. H. Rösner

Institute of Zoology

Cell- and Neurobiology

University of Hohenheim-Stuttgart

Garbenstraße 30

70593 Stuttgart

Germany

Telefon: +49/711/459 225 25

Fax: +49/711/459 234 50

eMail: roesnerh@uni-hohenheim.de

    >